www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

US EUROPE AFRICA ASIA 中文
Business / Industries

Pharmaceutical sector ripe for innovation

By Helen Chui (China Daily) Updated: 2014-07-15 06:57

Pharmaceutical sector ripe for innovation

The booth of Novartis Group (China) at an international medical conference in Beijing. The European Union Industrial Research and Development Investment Scoreboard 2013 shows that the pharmaceutical and biotech industry is the biggest spender on R&D in Europe. WU CHANGQING/CHINA DAILY

Innovation is a bold pursuit for any organization or government. In striving for something new and something better, there is one self-evident truth: Innovation is all about making the world better for all of us.

As China's economy is being steered toward a growth model in which knowledge and technology are playing a key role, innovation is becoming increasingly important and vigorously promoted. Premier Li Keqiang reaffirmed this position recently, saying China will strive to make innovation a driving force of the country's economic upgrading.

China has made great efforts to increase its innovation capabilities to drive further economic growth by generating new products, markets and jobs, leading to increased productivity and upgraded industries.

Pharmaceutical sector ripe for innovation
Pharmaceutical sector ripe for innovation
Implementing measurable and practical innovation and creativity is not a simple task. This is especially evident in the pharmaceutical industry; it is estimated to take $1 billion to $2 billion and 15 to 20 years to bring a new product to market.

The European Union Industrial Research and Development Investment Scoreboard 2013 shows the pharmaceutical and biotech industry is the biggest spender on R&D in Europe and, globally, five pharma and biotech companies, including Novartis International AG, are among the top 10 R&D investors.

Meaningful innovation takes time and a long-term outlook. New medications and treatments can take many years to pass through the development pipeline.

There are positive signs that China's pharmaceutical industry is making innovative R&D efforts. To support their efforts and elevate the industry's innovation capabilities, we need to build a thriving R&D ecosystem for which a rewarding policy environment is a key element.

China's government has shown a commitment to R&D investment. However, translating the investment into innovation in the form of products or business culture requires additional efforts, including an open and fair regulatory environment.

The rate of technology commercialization in China is 10 percent, while that for Organization of Economic Cooperation and Development countries is 40 percent. China could rethink its innovation framework to ensure its robust investment will lead to improved innovation capabilities and greater transfer of technology to the marketplace.

Three main pillars are crucial for the creation of a robust national framework to support innovation in the healthcare field.

First, upgrade public investment in basic R&D. The ratio of government investment in basic R&D is improving and increased financial support to universities and public research institutes would have a major effect.

Previous Page 1 2 Next Page

Hot Topics

Editor's Picks
...
...
主站蜘蛛池模板: 99热久久精品免费精品 | 国产三级精品久久三级国专区 | 黄色成人免费观看 | 女人张开腿让男人插 | 女女互操 | a级国产乱理伦片在线观看国 | 久久毛片免费 | 成人夜色香网站在线观看 | 99精品久久99久久久久 | 久久精品久久精品久久 | 午夜美女久久久久爽久久 | 久久中文字幕在线观看 | 国产精品视频999 | 国产一级精品高清一级毛片 | 性国产精品| 中文无线乱码二三四区 | 久草在线免费资源 | 日本阿v精品视频在线观看 日本阿v视频在线观看高清 | 欧美一级特黄乱妇高清视频 | 精品国产自| 精品久久网站 | 国产精品99久久免费观看 | 亚洲国产成a人v在线观看 | 亚洲欧美综合视频 | 亚洲一区二区在线视频 | 91挑色| 欧美freesex10一13黑人 | 免费午夜扒丝袜www在线看 | 成人毛片免费观看视频在线 | 国产综合成人久久大片91 | 欧美精品一区二区在线观看 | 伊人色综合7777 | 国产精品18久久久久久久久久 | 青青草国产免费一区二区 | 中文字幕 日韩在线 | 欧美中文字幕一区二区三区 | 久久久久琪琪去精品色村长 | 男人的天堂中文字幕 | 免费人成在线观看 | 国产猛烈无遮掩视频免费网站男女 | 欧美日韩在线视频观看 |